ERBB2 and breast carcinoma: Three primary biomarkers are known for differential expression in most breast cancer types, namely the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [2], and breast cancer shows different positive or negative expression combinations for these three markers.